RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
0.9800
-0.0200 (-2.00%)
Mar 31, 2025, 2:24 PM EDT - Market open
RenovoRx Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for RenovoRx stock have an average target of 6.00, with a low estimate of 3.00 and a high estimate of 9.00. The average target predicts an increase of 512.24% from the current stock price of 0.98.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for RenovoRx stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $3 | Strong Buy | Initiates | $3 | +206.12% | Mar 27, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $8.25 → $9 | Strong Buy | Maintains | $8.25 → $9 | +818.37% | Dec 10, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $8 → $8.25 | Strong Buy | Maintains | $8 → $8.25 | +741.84% | Sep 12, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +716.33% | Jun 17, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +308.16% | Feb 2, 2024 |
Financial Forecast
Revenue This Year
216.32M
from 112.81M
Increased by 91.76%
Revenue Next Year
n/a
from 216.32M
EPS This Year
-0.39
from -0.99
EPS Next Year
-0.38
from -0.39
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | n/a | 1.1M | 25.6M | |||
| Avg | n/a | 339,997 | 14.0M | |||
| Low | n/a | n/a | 2.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | 7,428.9% | |||
| Avg | - | - | 4,006.8% | |||
| Low | - | - | 764.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.38 | -0.32 | -0.01 |
| Avg | -0.39 | -0.38 | -0.12 |
| Low | -0.39 | -0.45 | -0.23 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.